San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.
DEVICES: Company Gains Advantage By Partnering With Insurer
Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.
A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.
San Diego biotech Neurocrine reported a big increase in revenue following the launch of a nervous system drug in late spring, according to financial results released Feb. 13.
An Encinitas developer has struck a deal to buy Palomar Health’s downtown Escondido hospital campus for $18 million, paving the way for a mixed-use project that’s poised to be the epicenter of a construction boom in the area.
San Diego medical device maker Tandem Diabetes Care recently announced a $60 million public stock offering.
ENERGY: Utility Still on Hook For Part of San Onofre Costs
San Diego Gas & Electric’s bottom line won’t be impacted by a proposed settlement that will cut by $775 million owed by ratepayers for the closure of the San Onofre nuclear plant.
Sirenas, a marine-centric biotech in San Diego, has entered into a research agreement with pharmaceutical giant Bristol-Myers Squibb.
Seated beside an oval table in his office, Kevin Sayer squints to read a text on his phone. His blue eyes — the same color as his button-down shirt – light up.
San Diego-based MKO Global Partners has been acquired by Two Labs, which provides product and commercialization services to pharmaceutical manufacturers.